ONO-4538 Study in Patients With Advanced Non-Small Cell Lung Cancer
NCT02175017
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
104
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Non-small Cell Lung Cancer (NSCLC)
Interventions
DRUG:
ONO-4538
DRUG:
ONO-4538
Sponsor
Ono Pharmaceutical Co., Ltd.